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Available online 15 June 2016Recent epidemiological research has indicated that the
incidence of fatty liver in the adult population has been
steadily increasing. Apart from obesity and hyperlipidemia
(especially an excessively high triglyceride level), alco-
holism, poorly controlled diabetes, hepatitis C, and drugs
(such as steroids and drugs to treat rheumatic immune
disorders) are also commonly seen factors that can induce
fatty liver. Although an assessment for fatty liver has
become a common part of health checkups, the general
public is not fully aware of its existence. Because the
condition has no pronounced clinical symptoms during the
early stage of the disease, most people are not aware of its
presence. From a clinical perspective, fatty liver fore-
shadows many clinical diseases. Fatty liver is defined as the
point when the liver’s fat content exceeds 5% of the weight
of a normal liver. When the liver contains excessive fat,
liver cells will gradually swell and eventually burst. At that
time, fat will flow out of the damaged cells and infiltrate
other liver cells. If the damaged liver cells cannot be
promptly repaired, this will lead to fatty hepatitis, and the
repair process will cause liver fibrosis, which may eventu-
ally lead to cirrhosis and liver cancer. In other words, the
people of Taiwan should be aware of fatty liver, and that itConflicts of interest: The authors declare no conflicts of
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(Figure 1).
Clinical imaging methods used to assess fatty liver
include computed tomography, magnetic resonance imag-
ing, and ultrasound. Among these, ultrasound is currently
the primary tool used to diagnose fatty liver. Ultrasound has
the advantages of being noninvasive, convenient, sensitive,
and highly reliable. In the hands of an experienced doctor,
it can be used to quickly determine how much fat has
accumulated in the liver. The vast majority of people
suffering from mild and moderate fatty liver were diag-
nosed when an ultrasound was performed during a physical
examination. There are specific clinical guidelines for the
ultrasound assessment of fatty liver [1]. The definition of
mild fatty liver is an echo from the hepatic parenchyma
that is slightly enhanced compared with the echo from the
renal parenchyma, while the blood vessels within the liver
and the diaphragm can be clearly identified as usual. In the
case of moderate fatty liver, the echo from some of the
hepatic parenchyma is again enhanced compared with that
from the renal parenchyma, but the blood vessels within
the liver and the diaphragm are increasingly vague and
blurry. In the case of severe fatty liver, compared with the
renal parenchyma, the hepatic parenchyma has an even
stronger echo, and the hepatic blood vessels, the dia-
phragm, and the rear part of the liver cannot be identified
in images. Furthermore, measurement of the thickness of
the fat in the cavities next to or around the kidneys can also
be used to assess the severity of fatty liver [2].
A considerable degree of subjectivity is involved when
ultrasound grayscale images are used to diagnose fatty
liver, and the physician’s experience is thereforef Ultrasound in Medicine. This is an open access article under the CC
).
Figure 1 Obesity is associated with various health risks, and among these fatty liver is very easily ignored, even though it is an
important health risk.
Figure 2 Ultrasound Nakagami imaging. (A) Normal liver. (B) Mild fatty liver. (C) Moderate fatty liver. (D) Severe fatty liver.
48 P.-H. Tsui, Y.-L. Wanimportant. The use of advanced technology using existing
ultrasound images in the diagnosis of fatty liver is currently
an urgent clinical priority. From a theoretical perspective,
the internal structure of different biological tissues differ,
which leads to differing sound wave interference effects,
which in turn result in different backscattering signals. In
this context, analysis of the characteristics of ultrasound
backscattering signals may improve the functional ultra-
sound imaging results obtained using ordinary system plat-
forms. The progression of fatty liver inevitably causes
changes in the structure of the hepatic parenchyma, which
will influence the stochastic characteristics of ultrasound
backscattering signals.
We have recently begun an investigation on the use of
Nakagami imaging in the diagnosis of fatty liver, and
developed ultrasound Nakagami parametric imaging based
on generalized Rayleigh scattering (i.e., the Nakagami
statistical model). In contrast with traditional ultrasound
grayscale imaging, Nakagami imaging uses the statistical
distribution of the raw ultrasound radiofrequency signals to
create images [3,4]. According to past studies, when
Nakagami parameters are < 1, this indicates that the
backscattering signal has a pre-Rayleigh statistical distri-
bution, and the tissue structure may contain small quanti-
ties of scatterers or strong scatterers. Nakagami
parameters equal to 1 indicate that a Rayleigh distribution
exists, and the tissue is a homogeneous medium. Nakagami
parameters > 1 indicate that a post-Rayleigh distributionexists, which means that tissue may contain periodic scat-
terers. The physical meaning of Nakagami parameters al-
lows physicians to determine the arrangement of scatterers
within the tissue, and their microstructure, distribution,
and concentration, which is information that cannot be
obtained from traditional grayscale images.
Figure 2 shows our preliminary results involving the use
of Nakagami imaging to diagnose fatty liver. It can be seen
that as the severity of fatty liver increases, the brightness
of Nakagami images also increases. Increased brightness in
Nakagami images indicates that the values of the Nakagami
parameters have increased, and the statistical distribution
of ultrasound backscattering has shifted from a pre-
Rayleigh distribution to a Rayleigh distribution. The mech-
anism causing this phenomenon is an increase in the con-
centration of oil droplets (scatterers) in the hepatic
parenchyma. One of the features of ultrasound Nakagami
imaging is the provision of quantitative information con-
cerning the concentration of scatterers. In the future, we
will investigate further the applications of ultrasound
Nakagami imaging in other medical conditions.References
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